Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Waldmann

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
European Journal of Immunology|January 18, 2014
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challengeNatasha Whibley, Donna M Maccallum, Mark A Vickers, et al.
European Journal of Immunology|April 8, 2010
Tolerogenicity is not an absolute property of a dendritic cellClaire A Farquhar, Alison M Paterson, Stephen P Cobbold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2009
MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activationDuncan Howie, Kathleen F Nolan, Stephen Daley, et al.
Genome Medicine|September 22, 2018
Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cellsCherry S Leung, Kevin Y Yang, Xisheng Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Blood|April 20, 2004
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administrationGeoff Hale, Peppy Rebello, Lee R Brettman, et al.
The Journal of Experimental Medicine|July 8, 2018
Foxp3<sup>+</sup> T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8<sup>+</sup> T cell responseKrista Stockenhuber, Ahmed N Hegazy, Nathaniel R West, et al.
Immunological Reviews|November 18, 2003
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanismsStephen P Cobbold, Kathleen F Nolan, Luis Graca, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
European Journal of Immunology|January 18, 2014
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challengeNatasha Whibley, Donna M Maccallum, Mark A Vickers, et al.
European Journal of Immunology|April 8, 2010
Tolerogenicity is not an absolute property of a dendritic cellClaire A Farquhar, Alison M Paterson, Stephen P Cobbold, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2009
MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activationDuncan Howie, Kathleen F Nolan, Stephen Daley, et al.
Genome Medicine|September 22, 2018
Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cellsCherry S Leung, Kevin Y Yang, Xisheng Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Blood|April 20, 2004
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administrationGeoff Hale, Peppy Rebello, Lee R Brettman, et al.
The Journal of Experimental Medicine|July 8, 2018
Foxp3<sup>+</sup> T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8<sup>+</sup> T cell responseKrista Stockenhuber, Ahmed N Hegazy, Nathaniel R West, et al.
Immunological Reviews|November 18, 2003
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanismsStephen P Cobbold, Kathleen F Nolan, Luis Graca, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
Pageof 16